IndraLab

Statements

LY 364947 decreases the amount of KCNH2. 1 / 1

| 1

reach

"Finally, in vivo administration of LY364947, a pharmacological antagonist of TGF-beta signalling, dramatically prevented interstitial fibrosis and LQTS and abolished aberrant expression of TGF-beta1, HERG, and Kir2.1 in ATO treated guinea pigs."

22853924

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

LY 364947 decreases the amount of KCNH2. 1 / 1

INDRA sources:

Databases

Reading